Cargando…

Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure

PURPOSE: Elderly heart failure (HF) patients have different clinical characteristics and poorer prognosis compared with younger patients. Prognostic risk scores for HF have not been validated well in elderly patients. We aimed to validate the Seattle Heart Failure Model (SHFM) and the Meta-Analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yalin, Chai, Ke, Zhu, Wanrong, Wan, Yuhao, Liang, Yaodan, Du, Minghui, Li, Yingying, Sun, Ning, Yang, Jiefu, Wang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453434/
https://www.ncbi.nlm.nih.gov/pubmed/34556979
http://dx.doi.org/10.2147/CIA.S323979
_version_ 1784570270222123008
author Cheng, Yalin
Chai, Ke
Zhu, Wanrong
Wan, Yuhao
Liang, Yaodan
Du, Minghui
Li, Yingying
Sun, Ning
Yang, Jiefu
Wang, Hua
author_facet Cheng, Yalin
Chai, Ke
Zhu, Wanrong
Wan, Yuhao
Liang, Yaodan
Du, Minghui
Li, Yingying
Sun, Ning
Yang, Jiefu
Wang, Hua
author_sort Cheng, Yalin
collection PubMed
description PURPOSE: Elderly heart failure (HF) patients have different clinical characteristics and poorer prognosis compared with younger patients. Prognostic risk scores for HF have not been validated well in elderly patients. We aimed to validate the Seattle Heart Failure Model (SHFM) and the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score in an elderly Chinese HF cohort. PATIENTS AND METHODS: This retrospective study enrolled 675 elderly HF patients (age≥70 years) discharged from our hospital between 2012 and 2017. The performance of the two risk scores was evaluated in terms of discrimination, using receiver-operating characteristic analysis, and calibration using a calibration plot and Hosmer–Lemeshow (H-L) test. Absolute risk reclassification was used to compare the two scores. RESULTS: During the mean follow-up time of 32.6 months, 193 patients (28.6%) died, and 1-year mortality was 10.5%. The predicted median 1-year mortality was 8% for the SHFM and 18% for the MAGGIC score. A Kaplan–Meier survival curve demonstrated that event rates of all-cause mortality significantly increased with increasing SHFM and MAGGIC scores. The discriminatory capacity of the SHFM was greater than that of the MAGGIC score (c-statistics were 0.72 and 0.67, respectively; P = 0.05). The calibration plot for the SHFM was better than that for MAGGIC score for 1-year mortality (SHFM: H-L χ(2) =8.2, P = 0.41; MAGGIC: H-L χ(2) =18.8, P =0.02). Compared with the MAGGIC score, the net reclassification index (NRI) of the SHFM was 2.96% (Z=5.88, P< 0.0001). CONCLUSION: The SHFM performs better than MAGGIC score, having good discrimination, calibration and risk classification for the prediction of 1-year mortality in elderly Chinese HF patients.
format Online
Article
Text
id pubmed-8453434
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84534342021-09-22 Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure Cheng, Yalin Chai, Ke Zhu, Wanrong Wan, Yuhao Liang, Yaodan Du, Minghui Li, Yingying Sun, Ning Yang, Jiefu Wang, Hua Clin Interv Aging Original Research PURPOSE: Elderly heart failure (HF) patients have different clinical characteristics and poorer prognosis compared with younger patients. Prognostic risk scores for HF have not been validated well in elderly patients. We aimed to validate the Seattle Heart Failure Model (SHFM) and the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score in an elderly Chinese HF cohort. PATIENTS AND METHODS: This retrospective study enrolled 675 elderly HF patients (age≥70 years) discharged from our hospital between 2012 and 2017. The performance of the two risk scores was evaluated in terms of discrimination, using receiver-operating characteristic analysis, and calibration using a calibration plot and Hosmer–Lemeshow (H-L) test. Absolute risk reclassification was used to compare the two scores. RESULTS: During the mean follow-up time of 32.6 months, 193 patients (28.6%) died, and 1-year mortality was 10.5%. The predicted median 1-year mortality was 8% for the SHFM and 18% for the MAGGIC score. A Kaplan–Meier survival curve demonstrated that event rates of all-cause mortality significantly increased with increasing SHFM and MAGGIC scores. The discriminatory capacity of the SHFM was greater than that of the MAGGIC score (c-statistics were 0.72 and 0.67, respectively; P = 0.05). The calibration plot for the SHFM was better than that for MAGGIC score for 1-year mortality (SHFM: H-L χ(2) =8.2, P = 0.41; MAGGIC: H-L χ(2) =18.8, P =0.02). Compared with the MAGGIC score, the net reclassification index (NRI) of the SHFM was 2.96% (Z=5.88, P< 0.0001). CONCLUSION: The SHFM performs better than MAGGIC score, having good discrimination, calibration and risk classification for the prediction of 1-year mortality in elderly Chinese HF patients. Dove 2021-09-16 /pmc/articles/PMC8453434/ /pubmed/34556979 http://dx.doi.org/10.2147/CIA.S323979 Text en © 2021 Cheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Cheng, Yalin
Chai, Ke
Zhu, Wanrong
Wan, Yuhao
Liang, Yaodan
Du, Minghui
Li, Yingying
Sun, Ning
Yang, Jiefu
Wang, Hua
Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure
title Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure
title_full Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure
title_fullStr Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure
title_full_unstemmed Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure
title_short Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure
title_sort performance of prognostic risk scores in elderly chinese patients with heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453434/
https://www.ncbi.nlm.nih.gov/pubmed/34556979
http://dx.doi.org/10.2147/CIA.S323979
work_keys_str_mv AT chengyalin performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT chaike performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT zhuwanrong performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT wanyuhao performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT liangyaodan performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT duminghui performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT liyingying performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT sunning performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT yangjiefu performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure
AT wanghua performanceofprognosticriskscoresinelderlychinesepatientswithheartfailure